Multiple tumor-suppressor genes on chromosome 3p contribute to head and neck squamous cell carcinoma tumorigenesis
- PMID: 20657180
- PMCID: PMC3093810
- DOI: 10.4161/cbt.10.7.12886
Multiple tumor-suppressor genes on chromosome 3p contribute to head and neck squamous cell carcinoma tumorigenesis
Abstract
Head and neck squamous cell carcinoma (HNSCC) remains a significant cause of morbidity and mortality. There has been a great interest in finding specific genomic changes which contribute to HNSCC tumorigenesis, especially within the chromosome 3p area, where high frequency of LOH (loss of heterozygosity) has been reported. However, tumor-suppressor genes that may account for the frequent LOH remain to be identified. Recently, one systematic study of genomic sequencing was performed on breast and colorectal cancers and 189 candidate cancer genes (CAN-genes) were reported. Among those CAN-genes, 13 genes are located on chromosome 3p. To investigate whether any of the 13 CAN-genes on chromosome 3p is relevant to HNSCC tumorigenesis, we examined their mutational profiles in eight HNSCC cell lines and 12 tumor-normal pairs of human HNSCC in this study. Three of the 13 CAN-genes, ALS2CL, EPHA3, and CMYA1, each was found to harbor a missense mutation (1/20, 5% for each of the three genes). The mutations appeared hemizygous and SNP array analyses showed that these missense mutations are accompanied by LOH on the remaining allele. In summary, our data offer further support that ALS2CL, EPHA3, and CMYA1 are bona-fide tumor-suppressor genes and contribute to the tumorigenesis of HNSCC. Our data suggest that multiple tumor-suppressor genes are likely to be involved in accounting for the high LOH on chromosome 3p in HNSCC.
Figures


Similar articles
-
Genomic assessments of the frequent loss of heterozygosity region on 8p21.3-p22 in head and neck squamous cell carcinoma.Cancer Genet Cytogenet. 2007 Jul 15;176(2):100-6. doi: 10.1016/j.cancergencyto.2007.04.003. Cancer Genet Cytogenet. 2007. PMID: 17656251 Free PMC article.
-
Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.Eur J Cancer. 2002 Aug;38(12):1585-92. doi: 10.1016/s0959-8049(01)00422-1. Eur J Cancer. 2002. PMID: 12142046
-
Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.J Oral Pathol Med. 2014 Jan;43(1):20-7. doi: 10.1111/jop.12087. Epub 2013 Jun 10. J Oral Pathol Med. 2014. PMID: 23750501
-
DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review.Head Neck. 2008 Oct;30(10):1361-83. doi: 10.1002/hed.20861. Head Neck. 2008. PMID: 18642290 Free PMC article. Review.
-
3q26-29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes.FEBS J. 2017 Sep;284(17):2705-2731. doi: 10.1111/febs.14061. Epub 2017 May 3. FEBS J. 2017. PMID: 28317270 Review.
Cited by
-
Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms.Biochemistry. 2012 Feb 21;51(7):1464-75. doi: 10.1021/bi2014079. Epub 2012 Feb 8. Biochemistry. 2012. PMID: 22242939 Free PMC article.
-
Simultaneous detection of 5-methylcytosine and 5-hydroxymethylcytosine at specific genomic loci by engineered deaminase-assisted sequencing.Chem Sci. 2024 May 20;15(26):10073-10083. doi: 10.1039/d4sc00930d. eCollection 2024 Jul 3. Chem Sci. 2024. PMID: 38966352 Free PMC article.
-
Characterization and identification of PARM-1 as a new potential oncogene.Mol Cancer. 2013 Jul 31;12:84. doi: 10.1186/1476-4598-12-84. Mol Cancer. 2013. PMID: 23902727 Free PMC article.
-
Recent advances in biomarkers and potential targeted therapies in head and neck squamous cell carcinoma.ISRN Surg. 2012;2012:715743. doi: 10.5402/2012/715743. Epub 2012 Feb 15. ISRN Surg. 2012. PMID: 22523710 Free PMC article.
-
Hypoxia-induced circPLOD2a/b promotes the aggressiveness of glioblastoma by suppressing XIRP1 through binding to HuR.Commun Biol. 2025 Jan 17;8(1):71. doi: 10.1038/s42003-025-07503-3. Commun Biol. 2025. PMID: 39820362 Free PMC article.
References
-
- De Schutter H, Spaepen M, Mc Bride WH, Nuyts S. The clinical relevance of microsatellite alterations in head and neck squamous cell carcinoma: a critical review. Eur J Hum Genet. 2007;15:734–741. - PubMed
-
- Chung CH, Levy S, Yarbrough WG. Clinical applications of genomics in head and neck cancer. Head Neck. 2006;28:360–368. - PubMed
-
- Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 1996;56:3630–3633. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous